Premium
Randomised clinical study: gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non‐coeliac gluten sensitivity
Author(s) -
Zanini B.,
Baschè R.,
Ferraresi A.,
Ricci C.,
Lanzarotto F.,
Marullo M.,
Villanacci V.,
Hidalgo A.,
Lanzini A.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13372
Subject(s) - medicine , indigestion , gluten , gastroenterology , wheat allergy , gluten free , coeliac disease , immunology , allergy , disease , pathology , food allergy
Summary Background It is unknown whether symptoms in non‐coeliac patients (non‐ CD ) meeting clinical diagnostic criteria for noncoeliac gluten sensitivity ( NCGS ) are specifically triggered by gluten. Aim To assess gluten sensitivity in patients diagnosed with NCGS . Methods We studied 35 non‐ CD subjects (31 females) that were on a gluten‐free diet ( GFD ), in a double‐blind challenge study. Participants were randomised to receive either gluten‐containing flour or gluten‐free flour for 10 days, followed by a 2‐week washout period and were then crossed over. The main outcome measure was their ability to identify which flour contained gluten. Secondary outcome measures were based upon Gastrointestinal Symptoms Rating Scale ( GSRS ) scores. Results The gluten‐containing flour was correctly identified by 12 participants (34%), who were classified as having NCGS . Their mean GSRS dimension scores were significantly higher following gluten challenge compared to baseline. The scores were: pain, 1.7 ± 0.8 vs. 2.6 ± 1.0; reflux, 1.6 ± 0.5 vs. 2.2 ± 0.9; indigestion, 1.9 ± 0.7 vs. 3.2 ± 1.1; diarrhoea, 1.6 ± 0.7 vs. 2.9 ± 1.5 and constipation, 1.9 ± 0.9 vs. 2.9 ± 1.3. Seventeen participants (49%) erroneously considered the gluten‐free flour to contain gluten. Their mean GSRS dimension scores were significantly higher following gluten‐free flour challenge compared to baseline. The scores were: pain, 1.6 ± 0.9 vs. 3.0 ± 0.9; reflux, 1.4 ± 0.5 vs. 2.3 ± 1.1; indigestion, 2.0 ± 1.1 vs. 3.7 ± 1.1; diarrhoea, 1.6 ± 0.7 vs. 3.0 ± 1.2 and constipation, 1.6 ± 0.9 vs. 2.6 ± 1.3. The other six participants (17%) were unable to distinguish between the flours. Conclusion Double‐blind gluten challenge induces symptom recurrence in just one‐third of patients fulfilling the clinical diagnostic criteria for non‐coeliac gluten sensitivity .